跳至主要内容
临床试验/NCT02507986
NCT02507986终止不适用

Mobile Phones in Cryptogenic Stroke Patients Bringing Single Lead ECGs to Detect Atrial Fibrillation

Leiden University13 个研究点 分布在 2 个国家目标入组 57 人开始时间: 2016年7月29日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
57
试验地点
13
主要终点
Percentage of detected atrial fibrillation

研究概览

简要总结

The main objective of this study is to compare the incidence of detected atrial fibrillation (AF) in cryptogenic stroke patients by a single lead ECG device with the incidence of detected AF by a 7-Day Holter ECG.

详细描述

Rationale: A standard work-up of stroke patients to identify a cause of stroke consists of Computed Tomography (CT), CT angiography of head and neck arteries, transthoracic echocardiography, 12-lead 10-seconds electrocardiogram (ECG), blood tests and 24-hour ECG monitoring. A stroke is called "cryptogenic" if no cause can be determined after standard work-up. Current detection of atrial fibrillation (AF) after stroke is 2.0%. Recent studies revealed that prolonged monitoring yields higher percentages of detected AF (12.0%). Devices used in these trials suffer from drawbacks. The investigators' hypothesis is that a new, smartphone compatible device, producing a single lead ECG (single lead ECG device), can be used for prolonged ECG monitoring in cryptogenic stroke patients.

Objective: The main objective of this study is to compare the incidence of detected AF in cryptogenic stroke patients by a single lead ECG device with the incidence of detected AF by a 7-Day Holter ECG.

Study design: A multicenter randomized trial. Study population: Cryptogenic stroke patients admitted to a hospital participating in the study. The calculated sample size is 200 (100 per arm).

Intervention: After inclusion, patients will be randomized to either a single lead ECG device or a 7-Day Holter Monitor.

Main study parameters/endpoints: The main endpoint will be the percentage of detected atrial fibrillation in both the single lead ECG device group and the 7-Day Holter group after one year.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients must have had an episode of symptomatic Transient ischemic attack (TIA) or episode of ischemic stroke.
  • Ischemic stroke is defined as an episode of transient or neurological dysfunction caused by focal brain or retinal ischemia with recent infarction on imaging
  • A TIA is defined as transient episode of neurologic dysfunction typically lasting less than one hour caused by focal brain or retinal ischemia without recent infarction on imaging.

排除标准

  • Known etiology of TIA or ischemic stroke
  • TIA or stroke caused by spinal ischemia
  • TIA only presenting with non-localising symptoms
  • Uncertainty about the diagnosis of TIA because of unclear clinical symptoms
  • Myocardial infarction <6 months before stroke
  • Coronary Artery Bypass Grafting <6 months before stroke
  • Severe valvular heart disease
  • Documented history of atrial fibrillation or atrial flutter
  • Permanent indication for oral anticoagulation at enrolment
  • Patient has permanent OAC contraindication
  • Patient is included in another randomized trial
  • Left ventricular aneurysm on echocardiography
  • Thrombus on echocardiographyRenal dysfunction (creatinine clearance <30 mL/min/1.73m2)
  • Patient has life expectancy of <1 year
  • Patient is not willing to sign the informed consent form
  • Patient is <18 years of age
  • Patient is considered an incapacitated adult
  • Patient is not in possession of a smartphone with Android Operating System (OS) or iOS.

结局指标

主要结局

Percentage of detected atrial fibrillation

时间窗: 1 year of follow-up

次要结局

  • Number of participants with a recurrent stroke or TIA as defined in the trial(Within one year after cryptogenic stroke)
  • Pro-Brain Natriuretic Peptide (Pro-BNP) levels in pg/mL(24 hours after cryptogenic stroke)
  • Left atrial diameter in cm/m2(24 hours after cryptogenic stroke)
  • Number of participants with a major bleeding(Within one year after cryptogenic stroke)
  • Percentages of atrial ectopy detected on 7-Day Holter monitor(7 days after cryptogenic stroke)
  • Left atrial volume in mL/m2(24 hours after cryptogenic stroke)

研究者

发起方
Leiden University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Serge A. Trines

S.A.I.P. Trines, Senior Cardiologist

Leiden University Medical Center

研究点 (13)

Loading locations...

相似试验